Labdoor

Labdoor

Growth Stage

Labdoor tests and reviews the purity and accuracy of 1,000+ supplements and CBD

Labdoor tests and reviews the purity and accuracy of 1,000+ supplements and CBD

Overview

Raised to Date: Raised: $153,467

Total Commitments ($USD)

Platform

Wefunder

Start Date

08/10/2022

Close Date

12/16/2022

Min. Goal
$50,000
Max. Goal
$1,070,000
Min. Investment

$100

Security Type

SAFE

Series

Series A

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$20,000,000

Discount

20%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

12/30/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,208

# of Investors

256

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2012

Industry

Healthcare & Pharmaceuticals

Tech Sector

Foodtech

Distribution Model

B2B/B2C

Margin

High

Capital Intensity

Low

Location

San Francisco, California

Business Type

Growth

Labdoor, with a valuation of $20 million, is raising funds on Wefunder. The company provides expert scientific reviews of consumer health products. It tests and reviews the purity and labels accuracy of over 1,000 products, including vitamins, supplements, and CBD. The certifications provided by Labdoor allow companies to compete with competitors on product quality rather than marketing hype. Neil Thanedar, Rafael Ferreira, and Helton Souza founded Labdoor in April 2012. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1,070,000. The campaign proceeds will be used for hiring a salesperson, hiring a researcher, marketing, research and development, and general and administrative costs.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$412,034

$473,156

COGS

$74,683

$41,360

Tax

$0

$0

 

 

Net Income

$-66,084

$134,457

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$8,661

$104,704

Accounts Receivable

$0

$0

Total Assets

$11,773

$107,523

Short-Term Debt

$46,962

$55,362

Long-Term Debt

$596,629

$617,895

Total Liabilities

$643,591

$673,257

Financials as of: 08/10/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Analyst Report Analyst Report Methodology Article

Like many Americans, I take a variety of supplements daily to stay healthy. I was a college athlete and fitness is still a major part of my life. I take a multivitamin, supplements that my doctor recommends, proteins after my workouts, and occasionally other pre-workout supplements. And I’m careful about the products I choose. I turn to user reviews and trusted nutritionist bloggers to pick which brands are best for my goals and my body. But aside from the education and certifications bloggers may hold, there is next to no scientific backing going into my decisions as a consumer. Given their popularity, it’s surprising that the U.S. Food and Drug Administration (FDA) does not approve dietary supplements. In fact, companies “often introduce a dietary supplement to the market without notifying the FDA,” and regulation often can’t actually begin until the product hits the market.

Labdoor is trying to fill this need by independently testing and certifying supplements, vitamins, protein, and cannabidiol (CBD) products for label accuracy and purity.

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Labdoor on Wefunder 2022
Platform: Wefunder
Security Type: SAFE
Valuation: $20,000,000

Follow company

Follow Labdoor on Wefunder 2022

Buy Labdoor's Deal Report

Warning: according to the close date for this deal, Labdoor may no longer be accepting investments.

Labdoor Deal Report

Get KingsCrowd’s comprehensive report on Labdoor including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Labdoor is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • Our deep-dive analyst report reviewing the deal's investment potential and bullish vs. bearish outlook

Buy the Labdoor deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge